American Journal of Clinical Oncology

OCT 5, 2026 · JOURNAL ARTICLE

Pancreatic Reirradiation: A Multi-Institutional Retrospective Analysis of Feasibility, Tolerability, and Clinical Outcomes

American Journal of Clinical Oncology

Objectives: With improvements in systemic therapy for pancreatic cancer (PC), the role of radiation therapy (RT) to optimize local control has increased. While the tolerability and

SEP 18, 2026 · JOURNAL ARTICLE

Clinical Outcomes of Sacituzumab Govitecan in Breast Cancer

American Journal of Clinical Oncology

Objectives: Sacituzumab govitecan (SG), a Trop-2–directed antibody-drug conjugate delivering SN-38, has shown promising activity in advanced breast cancer. However, variability acr

SEP 7, 2026 · JOURNAL ARTICLE

Efficacy and Safety of Savolitinib Plus Osimertinib in EGFR-Mutant, MET-Aberrant Advanced Non–Small Cell Lung Cancer

American Journal of Clinical Oncology

Meta-analysis of single-arm cohorts showing encouraging efficacy (ORR 53.9%) and manageable safety, but limited by lack of randomized comparator and reliance on surrogate endpoints; requires confirmatory RCT evidence.

AUG 10, 2026 · JOURNAL ARTICLE

Effects of Glucagon-Like Peptide-1 Receptor Agonists on Upper Gastrointestinal Adverse Events in Patients Receiving Platinum Analog-Based Chemotherapy

American Journal of Clinical Oncology

Single-center retrospective study without a control arm comparing GLP-1 RA users to non-users; observational design with potential confounding limits causal inference about GLP-1 RA's specific role in GI adverse events during platinum chemotherapy.